Research Pipeline: New Migraine Therapies in Development
You are currently watching a preview of this interview. Unlock the full version by upgrading to an Access Pass bundle! Get FREE access to 8 expert interviews from Day 1 and Day 2 when you register today!
- What new preventatives are in development?
- What new acute therapies are in development?
- When can we expect a cure?
Deborah I. Friedman, MD, MPH, FAAN
Professor of Neurology & Ophthalmology
University of Texas Southwestern Medical Center
Deborah I. Friedman, MD, MPH, is a professor in the departments of neurology and ophthalmology at the UT Southwestern Medical Center. Dr. Friedman is a neuro-ophthalmologist and headache medicine specialist, the founding director of UT Southwestern’s headache and facial pain program. Dr. Friedman is board-certified in neurology by the American Board of Psychiatry and Neurology, with subspecialty certification in headache medicine by the United Council for Neurologic Subspecialties. Dr. Friedman is a fellow of the American Academy of Neurology, the American Headache Society, and the North American Neuro-Ophthalmology Society.
Unlock all 32 expert interviews with your own copy of the 2022 Migraine World Summit. Includes:
- 32 expert interviews with seperate audio (MP3) files & transcripts
- 26 extended, uncut interview editions
- Lifetime access with no annual fee